NEOGAP Therapeutics AB
Entity

  • NEOGAP Therapeutics AB

    Created in 2016
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    1,997

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Visionsgatan 56b, 169 70 Solna, Sweden

    Stockholm

    Sweden

  • Employees

    Scale: 11-50

    Estimated: 27

  • Engaged corporates

    1
    0 1

  • Added in Motherbase

    8 months, 2 weeks ago
Description
  • Value proposition

    Science for cure.


    NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Therapeutic Immune Design, Centre for Molecular Medicine at Karolinska Institute, Stockholm, Sweden.

    Our vision is to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system.

    Our mission is to become an important player in the battle against cancer by development and commercialisation of our innovative cancer immunotherapy.

    Biopharmaceutical company, Immunotherapy, and Immuno-oncology

Corporate interactions BETA
Corporate TypeTweets Articles
Business Sweden
Business Sweden
Business Consulting and Services
Business Sweden
Business Consulting and Services 		Other

31 Oct 2024


Similar entities
Last news
Show all articles
Social network dynamics